Evidence map›Paper›PMID 41589778›Full record

ArticleJACC. Basic to translational science2026

Animal Models in Biomedical Research: Realities, Misconceptions, and Controversies.

Nikolaos G Frangogiannis

Abstract readEditorial
In one paragraph

Article in JACC. Basic to translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nikolaos G FrangogiannisThe Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: nikolaos.frangogiannis@einsteinmed.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

From early experimental physiology to modern mouse genetics, animal models have been central to the advancement of biomedical knowledge, enabling mechanistic insights into human disease and driving the development of transformative therapies. Animal model investigations have generated most of the key concepts in modern medicine and established therapeutic breakthroughs, including insulin replacement, renin-angiotensin system inhibition, lipid-lowering strategies, and cancer immunotherapy. Recent enthusiasm for new approach methodologies, such as organoids, microphysiological devices, and computational platforms, has prompted speculation that animal experimentation may be rendered obsolete. However, new approach methodologies remain reductionist and are incapable of reproducing the architectural, cellular, and integrative complexity of living organisms. Although animal studies face challenges related to research rigor, publication bias favoring low-probability findings, and disease heterogeneity, these limitations reflect problems rooted in current research practices rather than fundamental intrinsic flaws of the models. Animal experimentation therefore remains indispensable and irreplaceable for mechanistic discovery and therapeutic innovation.

Indexed as

animal modelsdiseaseorganoidspathophysiology

Identifiers

PMID41589778
PMCPMC12902268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.